BIOMAT Database Logo BIOMAT Database Logo

A randomized, controlled clinical trial comparing photochemotherapy with dithranol in the initial treatment of chronic plaque psoriasis. 1978

D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin

UI MeSH Term Description Entries
D008297 Male Males
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
A non-inferiority randomized controlled clinical trial comparing Unani formulation & psoralen plus ultraviolet A sol in chronic plaque psoriasis.
January 2018, The Indian journal of medical research,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
D-chiro-inositol as a treatment in plaque psoriasis: A randomized placebo-controlled clinical trial.
January 2021, Dermatologic therapy,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Azathioprine weekly pulse versus methotrexate for the treatment of chronic plaque psoriasis: A randomized controlled trial.
January 2021, Indian journal of dermatology, venereology and leprology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Treatment of chronic plaque psoriasis with dithranol and urea creams: a double-blind study.
January 1982, Pharmatherapeutica,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial.
April 2011, The British journal of dermatology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.
February 2004, The British journal of dermatology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial.
January 2015, The British journal of dermatology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate-to-severe chronic plaque-type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study.
March 2017, The British journal of dermatology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.
June 1977, The Journal of investigative dermatology,
D Vella Briffa, and S Rogers, and M W Greaves, and J Marks, and S Shuster, and A P Warin
[Moxibustion on plaque psoriasis of blood stasis: a randomized controlled trial].
July 2021, Zhongguo zhen jiu = Chinese acupuncture & moxibustion,
Copied contents to your clipboard!